The mechanism underlying the relationship between ADM, ANXA3, SLC22A4 and VIM and immune cells may be of great significance for the pathogenesis and progression of ischaemic stroke, and related research of these genes could provide new therapeutic insight for ischaemic stroke. This evidence concerns the gene ADM and ischemic stroke.